Comparison of quantitation of cytomegalovirus DNA by real-time pcr in whole blood with the cytomegalovirus antigenemia assay

Annals of Laboratory Medicine

Volumn 35, Issue 1, 2015, Pages 99-104

  Kwon, Seonhee ^a   Jung, Bo Kyeung ^a   Ko, Sun Young ^a   Lee, Chang Kyu ^a   Cho, Yunjung ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Antigenemia assay; Cytomegalovirus; Real time PCR

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; GANCICLOVIR; MATRIX PROTEIN; PHOSPHOPROTEIN; VIRUS DNA;

BLOOD; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENETICS; HUMAN; IMMUNOASSAY; IMMUNOLOGY; METABOLISM; ORGAN TRANSPLANTATION; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GANCICLOVIR; HUMANS; IMMUNOASSAY; ORGAN TRANSPLANTATION; PHOSPHOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL MATRIX PROTEINS; VIROLOGY;

EID: 84920532127     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2015.35.1.99     Document Type: Article

References (23)

1. Paya CV. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis 2001;32:596-603.
2. Boeckh M and Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998;11:533-54.
3. Allice T, Cerutti F, Pittaluga F, Varetto S, Franchello A, Salizzoni M, et al. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment. J Virol Methods 2008;148:9-16.
4. Guiver M, Fox AJ, Mutton K, Mogulkoc N, Egan J. Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV an-tigenemia in heart and lung transplant recipients. Transplantation 2001; 71:1609-15.
5. Camargo LF, Uip DE, Simpson AA, Caballero O, Stolf NA, Vilas-Boas LS, et al. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation. Transplantation 2001;71:412-7.
6. Heid CA, Stevens J, Livak KJ, Williams PM. Realtime quantitative PCR. Genome Res 1996;6:986-94.
7. Choi SM, Lee DG, Lim J, Park SH, Choi JH, Yoo JH, et al. Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoiet-ic stem cell transplant recipients. J Korean Med Sci 2009;24:571-8.
8. Marchetti S, Santangelo R, Manzara S, D'onghia S, Fadda G, Cattani P. Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants. New Microbiol 2011;34:157-64.
9. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-7.
10. Paya CV, Wilson JA, Espy MJ, Sia IG, DeBernardi MJ, Smith TF, et al. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial. J Infect Dis 2002;185:854-60.
11. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013; 96:333-60.
12. Griffiths PD and Whitley RJ, eds. Recommendations from the International Herpes Management Forum (IHMF) Managements Strategies Workshop and 8th Annual Meeting of the IHMF. The challenge of CMV infection and disease in transplantation.UK: Cambridge Medical Publications, 2000.
13. Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, et al. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hema-topoietic stem cell transplant recipients. J Med Virol 2004;73:412-8.
14. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, et al. The clinical use of various blood compartments for cytomegalovi-rus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002;73:968-73.
15. Von Müller L, Hampl W, Hinz J, Meisel H, Reip A, Engelmann E, et al. High variability between results of different in-house tests for cytomega-lovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay. J Clin Microbiol 2002;40:2285-7.
16. Heo WB, Won DI, Kim YL, Kim MH, Oh HB, Suh JS. Evaluation of Bi-osewoom Real-Q Cytomegalovirus Quantification kit for Cytomegalovirus viral load measure. Korean J Lab Med 2007;27:298-304.
17. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003;41:187-91.
18. Kalpoe JS, Kroes AC, de Jong MD, Schinkel J, de Brouwer CS, Beersma M F, et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004;42:1498-504.
19. Mhiri L, Kaabi B, Houimel M, Arrouji Z, Slim A. Comparison of pp65 an-tigenemia, quantitative PCR and DNA hybrid capture for detection of cy-tomegalovirus in transplant recipients and AIDS patients. J Virol Methods 2007;143:23-8.
20. Ghaffari SH, Obeidi N, Dehghan M, Alimoghaddam K, Gharehbaghian A, Ghavamzadeh A. Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR. Pathol Oncol Res 2008; 14:399-409.
21. Pillet S, Roblin X, Cornillon J, Mariat C, Pozzetto B. Quantification of cy-tomegalovirus viral load. Expert Rev Anti Infect Ther 2014;12:193-210.
22. Kim DJ, Kim SJ, Park J, Choi GS, Lee S, Kwon CD, et al. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients. Transplant Proc 2007;39: 1458-60.
23. Rhee JY, Peck KR, Lee NY, Song JH. Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalo-virus infection in kidney transplant recipients. Transplant Proc 2011;43:2624-9.